-
1
-
-
0026597063
-
Alzheimer's disease: The amyloid cascade hypothesis
-
Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256:184-185.
-
(1992)
Science
, vol.256
, pp. 184-185
-
-
Hardy, J.A.1
Higgins, G.A.2
-
2
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010;9:119-128.
-
(2010)
Lancet Neurol
, vol.9
, pp. 119-128
-
-
Jack, C.R.1
Knopman, D.S.2
Jagust, W.J.3
-
3
-
-
0026740795
-
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
-
Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
-
(1992)
Neurology
, vol.42
, pp. 631-639
-
-
Arriagada, P.V.1
Growdon, J.H.2
Hedley-Whyte, E.T.3
Hyman, B.T.4
-
4
-
-
0038117796
-
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
-
Naslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000;283:1571-1577.
-
(2000)
JAMA
, vol.283
, pp. 1571-1577
-
-
Naslund, J.1
Haroutunian, V.2
Mohs, R.3
-
5
-
-
1842510004
-
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
-
Ingelsson M, Fukumoto H, Newell KL, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004;62:925-931.
-
(2004)
Neurology
, vol.62
, pp. 925-931
-
-
Ingelsson, M.1
Fukumoto, H.2
Newell, K.L.3
-
6
-
-
67349184808
-
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
-
Price JL, McKeel DW Jr, Buckles VD, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009;30:1026-1036.
-
(2009)
Neurobiol Aging
, vol.30
, pp. 1026-1036
-
-
Price, J.L.1
McKeel, D.W.2
Buckles, V.D.3
-
7
-
-
35648932901
-
Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimer's disease
-
Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007;130: 2837-2844.
-
(2007)
Brain
, vol.130
, pp. 2837-2844
-
-
Pike, K.E.1
Savage, G.2
Villemagne, V.L.3
-
8
-
-
73349125078
-
Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment
-
Tolboom N, van der Flier WM, Yaqub M, et al. Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment. Neurology 2009;73:2079-2085.
-
(2009)
Neurology
, vol.73
, pp. 2079-2085
-
-
Tolboom, N.1
Van Der Flier, W.M.2
Yaqub, M.3
-
9
-
-
77950538370
-
Cognition, reserve, and amyloid deposition in normal aging
-
Rentz DM, Locascio JJ, Becker JA, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol 2010;67:353-364.
-
(2010)
Ann Neurol
, vol.67
, pp. 353-364
-
-
Rentz, D.M.1
Locascio, J.J.2
Becker, J.A.3
-
10
-
-
79960199327
-
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
-
Pike KE, Ellis KA, Villemagne VL, et al. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia 2011;49:2384-2390.
-
(2011)
Neuropsychologia
, vol.49
, pp. 2384-2390
-
-
Pike, K.E.1
Ellis, K.A.2
Villemagne, V.L.3
-
11
-
-
84857776667
-
APOE modifies the association between Ab load and cognition in cogni-tively normal older adults
-
Kantarci K, Lowe V, Przybelski SA, et al. APOE modifies the association between Ab load and cognition in cogni-tively normal older adults. Neurology 2012;78:232-240.
-
(2012)
Neurology
, vol.78
, pp. 232-240
-
-
Kantarci, K.1
Lowe, V.2
Przybelski, S.A.3
-
12
-
-
84870503989
-
Amyloid deposition detected with flor-betapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals
-
Sperling RA, Johnson KA, Doraiswamy PM, et al; AV45-A05 Study Group. Amyloid deposition detected with flor-betapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging 2013;34:822-831.
-
(2013)
Neurobiol Aging
, vol.34
, pp. 822-831
-
-
Sperling, R.A.1
Johnson, K.A.2
Doraiswamy, P.M.3
-
13
-
-
73549106106
-
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: Cognitive decline associated with Abeta deposition
-
Storandt M, Mintun MA, Head D, Morris JC. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol 2009;66:1476-1481.
-
(2009)
Arch Neurol
, vol.66
, pp. 1476-1481
-
-
Storandt, M.1
Ma, M.2
Head, D.3
Morris, J.C.4
-
14
-
-
77949408552
-
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C] PiB
-
Resnick SM, Sojkova J, Zhou Y, et al. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology 2010;74:807-815.
-
(2010)
Neurology
, vol.74
, pp. 807-815
-
-
Resnick, S.M.1
Sojkova, J.2
Zhou, Y.3
-
15
-
-
79551495391
-
Longitudinal assessment of Ab and cognition in aging and Alzheimer disease
-
Villemagne VL, Pike KE, Chételat G, et al. Longitudinal assessment of Ab and cognition in aging and Alzheimer disease. Ann Neurol 2011;69:181-192.
-
(2011)
Ann Neurol
, vol.69
, pp. 181-192
-
-
Villemagne, V.L.1
Pike, K.E.2
Chételat, G.3
-
16
-
-
84864944776
-
CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects
-
Ewers M, Insel P, Jagust WJ, et al; Alzheimer's Disease Neuroimaging Initiative (ADNI). CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex 2012;22:1993-2004.
-
(2012)
Cereb Cortex
, vol.22
, pp. 1993-2004
-
-
Ewers, M.1
Insel, P.2
Jagust, W.J.3
-
17
-
-
84862735174
-
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
-
Landau SM, Mintun MA, Joshi AD, et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol 2012;72:578-586.
-
(2012)
Ann Neurol
, vol.72
, pp. 578-586
-
-
Landau, S.M.1
Ma, M.2
Joshi, A.D.3
-
18
-
-
84871200927
-
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
-
Lim YY, Ellis KA, Pietrzak RH, et al. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology 2012;79:1645-1652.
-
(2012)
Neurology
, vol.79
, pp. 1645-1652
-
-
Lim, Y.Y.1
Ellis, K.A.2
Pietrzak, R.H.3
-
19
-
-
84871195205
-
Amyloid-b assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study
-
Doraiswamy PM, Sperling RA, Coleman RE, et al: AV45-A11 Study Group. Amyloid-b assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology 2012;79:1636-1644.
-
(2012)
Neurology
, vol.79
, pp. 1636-1644
-
-
Doraiswamy, P.M.1
Sperling, R.A.2
Coleman, R.E.3
-
20
-
-
84872463568
-
Rapid decline in episodic memory in healthy older adults with high amyloid-b
-
Lim YY, Pietrzak RH, Ellis KA, et al. Rapid decline in episodic memory in healthy older adults with high amyloid-b. J Alzheimers Dis 2013;33:675-679.
-
(2013)
J Alzheimers Dis
, vol.33
, pp. 675-679
-
-
Lim, Y.Y.1
Pietrzak, R.H.2
Ellis, K.A.3
-
21
-
-
84873392475
-
Decline in cognitive function over 18 months in healthy older adults with high amyloid-b
-
Ellis KA, Lim YY, Harrington K, et al. Decline in cognitive function over 18 months in healthy older adults with high amyloid-b. J Alzheimers Dis 2013;34:861-871.
-
(2013)
J Alzheimers Dis
, vol.34
, pp. 861-871
-
-
Ellis, K.A.1
Lim, Y.Y.2
Harrington, K.3
-
22
-
-
84876205585
-
Cognitive trajectories associated with b-amyloid deposition in the oldest-old without dementia
-
Snitz BE, Weissfeld LA, Lopez OL, et al. Cognitive trajectories associated with b-amyloid deposition in the oldest-old without dementia. Neurology 2013;80:1378-1384.
-
(2013)
Neurology
, vol.80
, pp. 1378-1384
-
-
Snitz, B.E.1
Weissfeld, L.A.2
Lopez, O.L.3
-
23
-
-
84892765470
-
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease
-
Lim YY, Maruff P, Pietrzak RH, et al. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain 2014;137:221-231.
-
(2014)
Brain
, vol.137
, pp. 221-231
-
-
Lim, Y.Y.1
Maruff, P.2
Pietrzak, R.H.3
-
24
-
-
55949117032
-
Frequent amyloid deposition without significant cognitive impairment among the elderly
-
Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 2008;65:1509-1517.
-
(2008)
Arch Neurol
, vol.65
, pp. 1509-1517
-
-
Aizenstein, H.J.1
Nebes, R.D.2
Saxton, J.A.3
-
25
-
-
84858341309
-
Cerebrovas-cular disease, b-amyloid, and cognition in aging
-
Marchant NL, Reed BR, DeCarli CS, et al. Cerebrovas-cular disease, b-amyloid, and cognition in aging. Neuro-biol Aging 2012;33:1006.e1025-e1036.
-
(2012)
Neuro-biol Aging
, vol.33
, pp. 1006e1025-1006e1036
-
-
Marchant, N.L.1
Reed, B.R.2
DeCarli, C.S.3
-
26
-
-
66549106850
-
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease
-
Jack CR Jr, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009;132:1355-1365.
-
(2009)
Brain
, vol.132
, pp. 1355-1365
-
-
Jack, C.R.1
Lowe, V.J.2
Weigand, S.D.3
-
27
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
-
28
-
-
84865529158
-
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
-
Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
-
(2012)
N Engl J Med
, vol.367
, pp. 795-804
-
-
Bateman, R.J.1
Xiong, C.2
Benzinger, T.L.3
-
29
-
-
84878794559
-
Developing an international network for Alzheimer research: The Domi-nantly Inherited Alzheimer Network
-
Morris JC, Aisen PS, Bateman RJ, et al. Developing an international network for Alzheimer research: The Domi-nantly Inherited Alzheimer Network. Clin Investig (Lond) 2012;2:975-984.
-
(2012)
Clin Investig (Lond)
, vol.2
, pp. 975-984
-
-
Morris, J.C.1
Aisen, P.S.2
Bateman, R.J.3
-
30
-
-
0027425211
-
The Clinical Dementia Rating (CDR): Current version and scoring rules
-
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
-
(1993)
Neurology
, vol.43
, pp. 2412-2414
-
-
Morris, J.C.1
-
31
-
-
0028278060
-
Protection against Alzheimer's disease with apoE epsilon 2
-
Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate A. Protection against Alzheimer's disease with apoE epsilon 2. Lancet 1994;343:1432-1433.
-
(1994)
Lancet
, vol.343
, pp. 1432-1433
-
-
Talbot, C.1
Lendon, C.2
Craddock, N.3
Shears, S.4
Morris, J.C.5
Goate, A.6
-
32
-
-
84856541277
-
Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families
-
Cruchaga C, Haller G, Chakraverty S, et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One 2012;7:e31039.
-
(2012)
PLoS One
, vol.7
, pp. e31039
-
-
Cruchaga, C.1
Haller, G.2
Chakraverty, S.3
-
33
-
-
84891481919
-
Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN)
-
Storandt M, Balota DA, Aschenbrenner AJ, Morris JC. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology 2014;28:19-29.
-
(2014)
Neuropsychology
, vol.28
, pp. 19-29
-
-
Storandt, M.1
Balota, D.A.2
Aschenbrenner, A.J.3
Morris, J.C.4
-
34
-
-
84888089112
-
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
-
Benzinger TL, Blazey T, Jack CR Jr, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci USA 2013;110: E4502-E4509.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. E4502-E4509
-
-
Benzinger, T.L.1
Blazey, T.2
Jack, C.R.3
-
35
-
-
84892402771
-
Quantitative analysis of PiB-PET with FreeSurfer ROIs
-
Su Y, D'Angelo GM, Vlassenko AG, et al. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLoS One 2013;8:e73377.
-
(2013)
PLoS One
, vol.8
, pp. e73377
-
-
Su, Y.1
D'Angelo, G.M.2
Vlassenko, A.G.3
-
36
-
-
84917726968
-
Partial volume correction in quantitative amyloid imaging
-
Su Y, Blazey TM, Snyder AZ, et al. Partial volume correction in quantitative amyloid imaging. Neuroimage 2015;107:55-64.
-
(2015)
Neuroimage
, vol.107
, pp. 55-64
-
-
Su, Y.1
Blazey, T.M.2
Snyder, A.Z.3
-
37
-
-
33747048954
-
PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
-
Mintun MA, Larossa GN, Sheline YI, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006;67:446-452.
-
(2006)
Neurology
, vol.67
, pp. 446-452
-
-
Ma, M.1
Larossa, G.N.2
Sheline, Y.I.3
-
38
-
-
84905868699
-
Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
-
Ryman DC, Acosta-Baena N, Aisen PS, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 2014;83:253-260.
-
(2014)
Neurology
, vol.83
, pp. 253-260
-
-
Ryman, D.C.1
Acosta-Baena, N.2
Aisen, P.S.3
-
39
-
-
84876385490
-
Meta-analysis of amyloid-cognition relations in cognitively normal older adults
-
Hedden T, Oh H, Younger AP, Patel TA. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology 2013;80:1341-1348.
-
(2013)
Neurology
, vol.80
, pp. 1341-1348
-
-
Hedden, T.1
Oh, H.2
Younger, A.P.3
Patel, T.A.4
-
40
-
-
84911430470
-
Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease
-
Sassi C, Guerreiro R, Gibbs R, et al. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease. Neurobiol Aging 2014;35: 2881.e2881-e2886.
-
(2014)
Neurobiol Aging
, vol.35
, pp. e2881-e2886
-
-
Sassi, C.1
Guerreiro, R.2
Gibbs, R.3
|